Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patriarca

Showing results (861-870 of 1,012) with videos related to

Pageof 102
Sort By:
Blood Advances|September 30, 2021
Evans syndrome in adults: an observational multicenter studyBruno Fattizzo, Marc Michel, Juri Alessandro Giannotta, et al.
Blood|April 15, 2011
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myelomaLuisa Giaccone, Barry Storer, Francesca Patriarca, et al.
Haematologica|June 22, 2019
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugsVittorio Montefusco, Francesca Gay, Stefano Spada, et al.
British Journal of Haematology|February 22, 2021
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective studyElisa Lucchini, Francesca Palandri, Stefano Volpetti, et al.
British Journal of Cancer|December 1, 2004
Classic Kaposi's sarcoma in Italy, 1985-1998L Dal Maso, J Polesel, V Ascoli, et al.
Cancer|October 6, 2023
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemiaFabio Efficace, Francesco Cottone, Betina Yanez, et al.
Frontiers in Microbiology|February 28, 2019
Cyclooxygenase (COX)-2 Inhibitors Reduce <i>Toxoplasma gondii</i> Infection and Upregulate the Pro-inflammatory Immune Response in <i>Calomys callosus</i> Rodents and Human Monocyte Cell LineAna Carolina Alcântara Pereira, Rafaela José Silva, Priscila Silva Franco, et al.
Oncotarget|October 26, 2016
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysisStefania Oliva, Manuela Gambella, Milena Gilestro, et al.
The Lancet. Haematology|January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trialAntonio Palumbo, Sara Bringhen, Davide Rossi, et al.
Pageof 102

Showing results (861-870 of 1,012) with videos related to

Sort By:
Pageof 102
Blood Advances|September 30, 2021
Evans syndrome in adults: an observational multicenter studyBruno Fattizzo, Marc Michel, Juri Alessandro Giannotta, et al.
Blood|April 15, 2011
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myelomaLuisa Giaccone, Barry Storer, Francesca Patriarca, et al.
Haematologica|June 22, 2019
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugsVittorio Montefusco, Francesca Gay, Stefano Spada, et al.
British Journal of Haematology|February 22, 2021
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective studyElisa Lucchini, Francesca Palandri, Stefano Volpetti, et al.
British Journal of Cancer|December 1, 2004
Classic Kaposi's sarcoma in Italy, 1985-1998L Dal Maso, J Polesel, V Ascoli, et al.
Cancer|October 6, 2023
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemiaFabio Efficace, Francesco Cottone, Betina Yanez, et al.
Frontiers in Microbiology|February 28, 2019
Cyclooxygenase (COX)-2 Inhibitors Reduce <i>Toxoplasma gondii</i> Infection and Upregulate the Pro-inflammatory Immune Response in <i>Calomys callosus</i> Rodents and Human Monocyte Cell LineAna Carolina Alcântara Pereira, Rafaela José Silva, Priscila Silva Franco, et al.
Oncotarget|October 26, 2016
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysisStefania Oliva, Manuela Gambella, Milena Gilestro, et al.
The Lancet. Haematology|January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trialAntonio Palumbo, Sara Bringhen, Davide Rossi, et al.
Pageof 102